Health Catalyst Inc (NASDAQ: HCAT) kicked off on Friday, up 6.77% from the previous trading day, before settling in for the closing price of $3.84. Over the past 52 weeks, HCAT has traded in a range of $3.49-$9.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 14.62%. While this was happening, its average annual earnings per share was recorded -12.27%. With a float of $66.24 million, this company’s outstanding shares have now reached $69.48 million.
Let’s determine the extent of company efficiency that accounts for 1500 employees. In terms of profitability, gross margin is 41.88%, operating margin of -20.39%, and the pretax margin is -23.2%.
Health Catalyst Inc (HCAT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Health Catalyst Inc is 4.83%, while institutional ownership is 80.04%. The most recent insider transaction that took place on Jun 05 ’25, was worth 23,925. Before that another transaction happened on Jun 02 ’25, when Company’s Officer proposed sale 3,255 for $3.63, making the entire transaction worth $11,831.
Health Catalyst Inc (HCAT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -12.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.89% during the next five years compared to 38.24% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Take a look at Health Catalyst Inc’s (HCAT) current performance indicators. Last quarter, stock had a quick ratio of 1.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Looking closely at Health Catalyst Inc (NASDAQ: HCAT), its last 5-days average volume was 0.92 million, which is a jump from its year-to-date volume of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 68.11%. Additionally, its Average True Range was 0.27.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 19.61%, which indicates a significant decrease from 87.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.48% in the past 14 days, which was lower than the 60.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.00, while its 200-day Moving Average is $6.20. However, in the short run, Health Catalyst Inc’s stock first resistance to watch stands at $4.19. Second resistance stands at $4.28. The third major resistance level sits at $4.43. If the price goes on to break the first support level at $3.95, it is likely to go to the next support level at $3.80. Now, if the price goes above the second support level, the third support stands at $3.71.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
The company with the Market Capitalisation of 285.37 million has total of 69,601K Shares Outstanding. Its annual sales at the moment are 306,580 K in contrast with the sum of -69,500 K annual income. Company’s last quarter sales were recorded 79,410 K and last quarter income was -23,740 K.
